Fundraising Fox
/Companies
Sign in

EsoCap Biotech

Switzerland, CH · 2 known investors

Find your way into EsoCap Biotech

Sign up to see every warm intro you have to EsoCap Biotech

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the EsoCap Biotech team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.

BiotechHealthtechMedical Devices

Founders & leadership

PD
Prof. Dr. Werner WeitschiesFounder and Chief Scientific Advisor
IRIsabelle Racamier
Isabelle RacamierCEOIsabelle Racamier is CEO of EsoCap Biotech, a clinical-stage biotech company developing treatments for esophageal diseases, and brings experience in clinical development, regulatory programs, and capital raising across European, US, and Asian markets.

Board

WT
Werner TschollarChairman of the Board

Investors · 2

sandstorm.vclisted by sandstorm.vcDubai · $50K – $500Kvia Camillo Schobesberger · inferred

Frequently asked questions

What does EsoCap Biotech do?
EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.
Who founded EsoCap Biotech?
EsoCap Biotech was founded by Prof. Dr. Werner Weitschies.
Who are EsoCap Biotech's investors?
EsoCap Biotech's investors include CARELA Holding GmbH, sandstorm.vc.
Where is EsoCap Biotech headquartered?
EsoCap Biotech is headquartered in Switzerland, CH.